Stocks and Investing
by (remove) : Christopher Raymond
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Christopher Raymond
RSSJSONXMLCSV
Mon, September 23, 2024
Thu, September 5, 2024
Tue, August 27, 2024
Fri, August 23, 2024
Thu, August 15, 2024
Fri, August 2, 2024
Fri, July 12, 2024
Tue, July 2, 2024
Mon, July 1, 2024
Tue, June 18, 2024
Fri, May 24, 2024
Tue, May 7, 2024
Fri, May 3, 2024
Mon, April 29, 2024
Tue, April 9, 2024
Fri, March 8, 2024
Fri, February 23, 2024
Wed, February 14, 2024
Fri, December 22, 2023
Wed, November 15, 2023
Thu, November 2, 2023
Wed, October 11, 2023
Fri, August 11, 2023
Fri, July 28, 2023
Thu, June 1, 2023
Wed, May 31, 2023
Thu, May 4, 2023
Fri, April 28, 2023
Thu, April 27, 2023

Christopher Raymond Maintained (BHVN) at Buy with Increased Target to $76 on, Sep 23rd, 2024


Published on 2024-10-28 14:25:16 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Biohaven Ltd." (BHVN) at Buy with Increased Target from $66 to $76 on, Sep 23rd, 2024.

Christopher has made no other calls on BHVN in the last 4 months.



There are 7 other peers that have a rating on BHVN. Out of the 7 peers that are also analyzing BHVN, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Christopher


  • Amy Li of "Jefferies" Initiated at Strong Buy and Held Target at $57 on, Monday, September 16th, 2024
  • Leonid Timashev of "RBC Capital" Reiterated at Buy and Held Target at $59 on, Wednesday, September 4th, 2024
  • William Pickering of "Bernstein" Initiated at Buy and Held Target at $55 on, Wednesday, September 4th, 2024
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy on, Monday, August 19th, 2024
  • Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $54 on, Tuesday, August 13th, 2024
  • Terence Flynn of "Morgan Stanley" Initiated at Buy and Held Target at $58 on, Wednesday, July 24th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $59 on, Thursday, May 30th, 2024
Contributing Sources